EA201591180A1 - Составы ингибитора lfa-1 - Google Patents
Составы ингибитора lfa-1Info
- Publication number
- EA201591180A1 EA201591180A1 EA201591180A EA201591180A EA201591180A1 EA 201591180 A1 EA201591180 A1 EA 201591180A1 EA 201591180 A EA201591180 A EA 201591180A EA 201591180 A EA201591180 A EA 201591180A EA 201591180 A1 EA201591180 A1 EA 201591180A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- lfa
- inhibitor
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Изобретение относится к композициям, способам и наборам для лечения заболеваний "сухой глаз". В частности, в описании раскрыты стабилизированные фармацевтические композиции, содержащие соединение формулы 1, для различных видов применения, включая лечение синдрома сухого глаза. В одном из аспектов описаны способы и ингредиенты для улучшения стабильности композиций соединения формулы 1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261739609P | 2012-12-19 | 2012-12-19 | |
US201361758147P | 2013-01-29 | 2013-01-29 | |
PCT/US2013/076041 WO2014100135A1 (en) | 2012-12-19 | 2013-12-18 | Lfa-1 inhibitor formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591180A1 true EA201591180A1 (ru) | 2015-12-30 |
EA028008B1 EA028008B1 (ru) | 2017-09-29 |
Family
ID=50979140
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591180A EA028008B1 (ru) | 2012-12-19 | 2013-12-18 | Составы ингибитора lfa-1 |
EA201791321A EA201791321A1 (ru) | 2012-12-19 | 2013-12-18 | Составы ингибитора lfa-1 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791321A EA201791321A1 (ru) | 2012-12-19 | 2013-12-18 | Составы ингибитора lfa-1 |
Country Status (21)
Country | Link |
---|---|
US (2) | US11058677B2 (ru) |
EP (2) | EP2934510B1 (ru) |
JP (1) | JP6373867B2 (ru) |
KR (1) | KR101891144B1 (ru) |
CN (1) | CN104955453B (ru) |
AU (1) | AU2013361579B2 (ru) |
BR (1) | BR112015014367B1 (ru) |
CA (1) | CA2894170C (ru) |
DK (1) | DK2934510T3 (ru) |
EA (2) | EA028008B1 (ru) |
ES (1) | ES2846724T3 (ru) |
HK (2) | HK1214536A1 (ru) |
HU (1) | HUE052299T2 (ru) |
IL (1) | IL239490B (ru) |
MX (2) | MX368876B (ru) |
NZ (1) | NZ708821A (ru) |
PL (1) | PL2934510T3 (ru) |
PT (1) | PT2934510T (ru) |
SI (1) | SI2934510T1 (ru) |
WO (1) | WO2014100135A1 (ru) |
ZA (2) | ZA201504404B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106995439B (zh) * | 2016-01-26 | 2019-09-20 | 镇江圣安医药有限公司 | 氘取代3-(甲磺酰基)-l-苯丙氨酸衍生物及其药物组合物、药物制剂和用途 |
WO2019171260A1 (en) * | 2018-03-09 | 2019-09-12 | Mankind Pharma Ltd. | Pharmaceutical composition of lifitegrast |
CN114025759A (zh) * | 2019-04-18 | 2022-02-08 | 阿祖拉眼科有限公司 | 用于治疗眼病的化合物和方法 |
EP3842032A1 (en) | 2019-12-24 | 2021-06-30 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | A pharmaceutical formulation |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2694719A (en) | 1949-02-12 | 1954-11-16 | Opplt Jan | Method of stabilizing ascorbic acid with alkali-thiosulfate-carbamide-complexes |
ES2098739T3 (es) * | 1992-05-13 | 1997-05-01 | Sandoz Ltd | Composiciones oftalmicas conteniendo una cyclosporin. |
US5429819A (en) * | 1992-10-14 | 1995-07-04 | Matsushita Electric Industrial Co., Ltd. | Antiviral composition |
IT1277707B1 (it) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
JP4138910B2 (ja) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
RU2149611C1 (ru) * | 1998-04-06 | 2000-05-27 | Московская медицинская академия им. И.М. Сеченова | Капли для лечения воспалительных заболеваний глаз (варианты) |
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
US6258814B1 (en) * | 2000-10-13 | 2001-07-10 | Schering Corporation | Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep |
US8877168B1 (en) * | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
CA2532207A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
FI119361B (fi) | 2003-09-26 | 2008-10-31 | Raute Oyj | Menetelmä viilun sorvaamiseksi |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
CN102617557A (zh) * | 2005-05-17 | 2012-08-01 | 萨可德生物科学公司 | 治疗眼病的组合物和方法 |
EP1901708B1 (en) * | 2005-07-08 | 2013-09-11 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
US7544893B2 (en) | 2007-07-25 | 2009-06-09 | Thomas & Betts International, Inc. | Extruded wire duct end cap |
ITRM20080182A1 (it) * | 2008-04-07 | 2009-10-08 | Medivis S R L | Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. |
WO2009139817A2 (en) * | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
US20090257957A1 (en) * | 2008-04-15 | 2009-10-15 | John Burnier | Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders |
US20090258070A1 (en) | 2008-04-15 | 2009-10-15 | John Burnier | Topical LFA-1 antagonists for use in localized treatment of immune related disorders |
US20120028929A1 (en) * | 2008-09-19 | 2012-02-02 | Alacrity Bioscience, Inc. | Tetracycline stabilizing formulations |
CN102176920B (zh) * | 2008-11-17 | 2013-09-18 | 莱拉制药用品私营有限责任公司 | 姜黄素及其用于治疗眼科疾病的方法 |
EA025414B1 (ru) * | 2009-06-10 | 2016-12-30 | Общество С Ограниченной Ответственностью "Митотех" | Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии |
KR20110001103A (ko) * | 2009-06-29 | 2011-01-06 | 에스케이케미칼주식회사 | 보관 안정성이 향상된 톨테로딘 함유 경피 투여 조성물 |
CN102712584B (zh) * | 2009-11-23 | 2014-10-29 | 阿勒根公司 | 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法 |
US20120190653A1 (en) * | 2011-01-20 | 2012-07-26 | Dow Pharmaceutical Sciences, Inc. | Therapeutic eye drop comprising doxycycline and a stabilizer |
US20130317058A1 (en) * | 2011-02-18 | 2013-11-28 | M/S. Appasamy Associates | Ophthalmic composition for enabling dilation of pupils |
JP2014518278A (ja) * | 2011-06-29 | 2014-07-28 | アラーガン インコーポレイテッド | 蕁麻疹の治療に用いるアルカフタジン |
WO2013148896A1 (en) * | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular treatment solutions, delivery devices and delivery augmentation methods |
CN103230583A (zh) * | 2013-05-17 | 2013-08-07 | 江西省创欣药业集团有限公司 | 兽用治疗肠道疾病的烟酸诺氟沙星复方注射液及制备方法 |
-
2013
- 2013-12-18 WO PCT/US2013/076041 patent/WO2014100135A1/en active Application Filing
- 2013-12-18 CN CN201380071760.5A patent/CN104955453B/zh active Active
- 2013-12-18 EA EA201591180A patent/EA028008B1/ru unknown
- 2013-12-18 US US14/650,955 patent/US11058677B2/en active Active
- 2013-12-18 NZ NZ708821A patent/NZ708821A/en unknown
- 2013-12-18 CA CA2894170A patent/CA2894170C/en active Active
- 2013-12-18 AU AU2013361579A patent/AU2013361579B2/en active Active
- 2013-12-18 ES ES13865757T patent/ES2846724T3/es active Active
- 2013-12-18 DK DK13865757.2T patent/DK2934510T3/da active
- 2013-12-18 JP JP2015549612A patent/JP6373867B2/ja active Active
- 2013-12-18 PL PL13865757T patent/PL2934510T3/pl unknown
- 2013-12-18 EA EA201791321A patent/EA201791321A1/ru unknown
- 2013-12-18 EP EP13865757.2A patent/EP2934510B1/en active Active
- 2013-12-18 BR BR112015014367-9A patent/BR112015014367B1/pt active IP Right Grant
- 2013-12-18 KR KR1020157019352A patent/KR101891144B1/ko active IP Right Grant
- 2013-12-18 SI SI201331833T patent/SI2934510T1/sl unknown
- 2013-12-18 MX MX2015007540A patent/MX368876B/es active IP Right Grant
- 2013-12-18 EP EP20204080.4A patent/EP3827823A1/en not_active Withdrawn
- 2013-12-18 HU HUE13865757A patent/HUE052299T2/hu unknown
- 2013-12-18 PT PT138657572T patent/PT2934510T/pt unknown
-
2015
- 2015-06-12 MX MX2019012375A patent/MX2019012375A/es unknown
- 2015-06-18 IL IL239490A patent/IL239490B/en active IP Right Grant
- 2015-06-18 ZA ZA2015/04404A patent/ZA201504404B/en unknown
-
2016
- 2016-03-08 HK HK16102642.0A patent/HK1214536A1/zh unknown
- 2016-03-15 HK HK16102972.0A patent/HK1214963A1/zh unknown
- 2016-11-22 ZA ZA2016/08069A patent/ZA201608069B/en unknown
-
2021
- 2021-06-09 US US17/342,631 patent/US20220000859A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
EA201290980A1 (ru) | Производные 1-амино-2-циклопропилэтилбороновой кислоты | |
MD20150043A2 (ru) | Ингибиторы гистон деметилаз | |
EA201492216A1 (ru) | Ингибиторы бромодомена и их применение | |
EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
EA201692506A2 (ru) | Ингибиторы репликации вирусов гриппа | |
EA201692166A1 (ru) | Гетероциклические ингибиторы глютаминазы | |
EA201500953A1 (ru) | 3-ацетиламино-1-(фенилгетероариламинокарбонил или фенилгетероарилкарбониламино)бензольные производные для лечения гиперпролиферативных нарушений | |
EA201391786A1 (ru) | Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
EA201400311A1 (ru) | Аминозамещенные имидазопиридазины | |
EA201400976A1 (ru) | Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена | |
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201490103A1 (ru) | Гидроксиметиларилзамещенные пирролотриазины в качестве ингибиторов alk1 | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
EA201691881A1 (ru) | Новые соединения | |
EA201790576A1 (ru) | Спироциклические ингибиторы катепсина с | |
EA201490846A1 (ru) | Новые производные арилхинолина | |
ATE555116T1 (de) | Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
EA201491500A1 (ru) | Способы лечения фиброза | |
EA201691962A1 (ru) | Амидозамещенные азольные соединения в качестве ингибиторов tnks1 и/или tnks2 | |
EA201792341A1 (ru) | Производные пиразола, пригодные в качестве ингибиторов белка, активирующего 5-липоксигеназу (flap) | |
EA201501187A1 (ru) | Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний | |
EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
EA201591180A1 (ru) | Составы ингибитора lfa-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment |